Consolidation Immunotherapy in Unresectable Early NSCLC: Novel Approaches

Sandip Patel, MD, shares his expert perspectives on novel combination consolidation immunotherapy regimens that are under evaluation in unresectable early-stage NSCLC.

Related Keywords

Sandip Patel , ,Recent Updates ,Translating Evidence ,Clinical Practice ,Unresectable Early ,Nsclc ,Early Nsclc ,Non Small Cell Lung Cancer ,Asco 2023 ,Localized Disease ,Presection ,Surgery ,Staging ,Chemoimmunotherapy ,Immunotherapy ,Ohio ,Molecular Testing ,Liquid Biopsy ,Tissue Biopsy ,Ngs Testing ,Egfr ,Talk ,